Danwang Medical vs ORGANOIDSCIENCES 오가노이드사이언스

Danwang Medical logo

Danwang Medical

Empowering medical advancements through regenerative medicine and organoid technology for precise diagnostics and innovative therapies

est. 2019

VS
ORGANOIDSCIENCES 오가노이드사이언스 logo

ORGANOIDSCIENCES 오가노이드사이언스

Commercialization of the world's first organoid treatment

44 employees · est. 2018 · Korea South

ORGANOIDSCIENCES 오가노이드사이언스 is the older company (2019 vs 2018).

Side-by-Side Comparison

Danwang Medical ORGANOIDSCIENCES 오가노이드사이언스
Founded
2019 2018 older
Headquarters
Not tracked yet Korea South
Employees
Not tracked yet 44
Industry
Biopharma, Biotechnology Biopharma, Biotechnology
Funding Stage
Series A Series B
Total Funding
$120.00M $26.02B
Funding Rounds
2 3
Taxonomy
Regenerative MedicineOrganoid TechnologyClinical TransformationDisease DiagnosisTreatmentDrug Sensitivity Testing +4 Organoid TreatmentDrug ScreeningRegenerative MedicineInnovationBio-techMedical Research +2
Website
d1med.com organoidrx.com
Danwang Medical logo

About Danwang Medical

Danwang Medical is a biopharma and biotechnology startup founded in 2019 with the slogan "Empowering medical advancements through regenerative medicine and organoid technology for precise diagnostics and innovative therapies." The company specializes in advanced clinical transformation technology se...

ORGANOIDSCIENCES 오가노이드사이언스 logo

About ORGANOIDSCIENCES 오가노이드사이언스

ORGANOIDSCIENCES is a Korean biotech startup founded in 2018 with a focus on the commercialization of the world's first organoid treatment. The company's innovative approach lies in utilizing organoid-based drug screening and regenerative medicines. With its recent $17.69M Series B investment on 13...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Danwang Medical and ORGANOIDSCIENCES 오가노이드사이언스 for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Danwang Medical or ORGANOIDSCIENCES 오가노이드사이언스 moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Danwang Medical was founded in 2019. Danwang Medical is a biopharma and biotechnology startup founded in 2019 with the slogan "Empowering medical advancements through regenerative medicine and organoid technology for precise diagnostics. ORGANOIDSCIENCES 오가노이드사이언스 was founded in 2018, based in Korea South, with 44 employees. ORGANOIDSCIENCES is a Korean biotech startup founded in 2018 with a focus on the commercialization of the world's first organoid treatment. The company's innovative approach lies in utilizing organoid.
Danwang Medical has raised $120.00M and ORGANOIDSCIENCES 오가노이드사이언스 $26.02B. Latest stage: Danwang Medical Series A, ORGANOIDSCIENCES 오가노이드사이언스 Series B.
Both work in Biopharma and Biotechnology and list regenerative medicine among their focus areas.

Compare Danwang Medical with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Danwang Medical on 12 Sep 2024, and ORGANOIDSCIENCES 오가노이드사이언스 on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes